Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 3.41B | $ 3.22B | $ 3.17B | $ 3.67B | $ 2.72B |
Total Assets | $ 19.02B | $ 20.52B | $ 18.57B | $ 17.44B | $ 14.80B |
Total Debt | $ 4.27B | $ 4.61B | $ 3.68B | $ 3.64B | $ 4.27B |
Net Debt | $ 858.63M | $ 1.39B | $ 500.72M | $ -32.21M | $ 1.55B |
Total Liabilities | - | - | - | - | - |
Stockholders Equity | $ 10.92B | $ 11.71B | $ 11.22B | $ 10.74B | $ 7.31B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | $ 2.27B | $ 2.32B | - | $ 1.92B | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |